openPR Logo
Press release

Atrial Septal Defect Market: Global Industry Analysis 2024

05-26-2017 01:08 AM CET | Health & Medicine

Press release from: Transparency Market Research

Atrial Septal Defect Market: Global Industry Analysis 2024

Global Atrial Septal Defect Market: Outlook

Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole is referred to as atrial septal defect. Huge and long-term atrial septal defects may lead to serious heart and lung damage. In some cases, extra blood volume can overfill the lungs and increases the blood pressure of the lungs, leading to pulmonary hypertension. Most of the congenital heart diseases are caused by certain genetic defects. The three most common types of atrial septal defects are ostium secundum atrial septal defect, ostium primum atrial septal defect and sinus venosus atrial septal. Various symptoms associated with atrial septal defect are as follows:

Difficulty in breathing (dyspnea)
Frequent respiratory infections
Swelling of legs and feet
Heart palpitations
Fatigue
Get accurate market forecast and analysis on the Atrial Septal Defect Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17066

Global Atrial Septal Defect Market: Key Segments

Based on diagnosis, the atrial septal defect market can be segmented as follows:

Electrocardiogram (ECG): ECG records the electrical activity of an individual and identifies heart problems
Chest X-ray: With the help of X-ray, condition of the heart and lungs are detected
Cardiac catheterization: In this test, a catheter is inserted into the heart via vein and any congenital heart defects can be diagnosed including amount of oxygen in the blood
Transesophageal echocardiography (TEE): The test provides an ultrasound image to provide a clearer image of the atria
Pulse oximetry: This test helps to detect whether oxygenated blood is mixing with deoxygenated blood, thereby confirming any type of heart defect
The medications which are used to reduce the signs and symptoms of atrial septal defect include beta blockers (Lopressor, Inderal), anticoagulants (Coumadin) and anti-platelet agents (aspirin). In some instances, surgery is also done to repair an atrial septal defect such as open-heart surgery and cardiac catheterization.

Global Atrial Septal Defect Market: Regional Analysis

Based on geography, the atrial septal defect market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these regions, North America holds a leading position in the market followed by Europe. The prime factors which are driving the growth of atrial septal defect market in these regions are high prevalence of genetic heart disorders, and growing awareness of the population regarding atrial septal defects. Moreover, technological advancement in the treatment of congenital heart diseases is also accentuating the growth of the market. Asia Pacific is the most lucrative market for the growth of atrial septal defect market. The advantageous factors which would propel the growth of the market in Asia Pacific are presence of large population base and emerging economies such as China, Malaysia, India and Vietnam. Furthermore, favorable reimbursement policies and increasing disposable income of the Asian population would further boost the growth of atrial septal defect market in the coming years.

Global Atrial Septal Defect Market: Companies Mentioned in the Report

Various pharmaceutical companies are constantly trying to come up with novel therapeutic developments for the treatment of atrial septal defect. Some of the top major players operating in the atrial septal defect market are Asklepion Pharmaceuticals, LLC, Actelion Ltd., Novo Nordisk A/S, Abbott Laboratories, INO Therapeutics, LLC and others.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/atrial-septal-defect-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Septal Defect Market: Global Industry Analysis 2024 here

News-ID: 552323 • Views:

More Releases from Transparency Market Research

Smart Food Packaging Market Outlook 2032: Expected to Reach US$ 8.0 Billion by 2032, Growing at a CAGR of 5.8% from 2024
Smart Food Packaging Market Outlook 2032: Expected to Reach US$ 8.0 Billion by 2 …
The global smart food packaging market (スマート食品包装市場) was valued at US$ 4.8 billion in 2023. It is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2032, reaching a valuation of US$ 8.0 billion by 2032. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85208&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst Viewpoint The introduction of novel food technologies due to rising consumer and industrial demand for safe and protective food packaging is a key
Retail Ready Packaging Market Outlook 2032: Projected to Reach US$ 102.2 Billion by 2032, Growing at a CAGR of 2.4% from 2024
Retail Ready Packaging Market Outlook 2032: Projected to Reach US$ 102.2 Billion …
The global retail ready packaging market (소매용 포장 시장) was valued at US$ 81.4 billion in 2023. It is projected to grow at a compound annual growth rate (CAGR) of 2.4% from 2024 to 2032, reaching US$ 102.2 billion by the end of 2032. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14105&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst Viewpoint The increase in the popularity of die cut display containers is a key factor driving the retail ready packaging market.
Packaging Automation Market Outlook 2032: Expected to Reach US$ 52.2 Billion by 2032, Growing at a CAGR of 3.7% from 2024
Packaging Automation Market Outlook 2032: Expected to Reach US$ 52.2 Billion by …
The global packaging automation market (包装自動化市場) was valued at US$ 37.5 billion in 2023. It is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2032, reaching US$ 52.2 billion by the end of 2032. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14096&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst Viewpoint The increase in efficiency through advanced packaging technologies is propelling the packaging automation market size. Automation improves efficiency, reduces errors, and enhances the
Brain Cancer Diagnostics Market Worth USD 2.5 Bn, at a 5.9% CAGR By 2031 - Trans …
Brain cancer remains one of the most challenging and complex malignancies to diagnose and treat. Advances in diagnostic technologies and methods are crucial for early detection and effective management of brain tumors. The global brain cancer diagnostics market, valued at approximately USD 1.5 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2031, reaching more than USD 2.5 billion by

All 5 Releases


More Releases for Atrial

Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole
Atrial Fibrillation Market Analysis, Forecast, and Assessment 2026
Increasing prevalence of common diseases and conditions such as obesity, diabetes, hypertension, etc., are leading to the risk of various heart problems. Moreover, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Along with the increasing number of people suffering from atrial fibrillation, especially among the geriatric population. There has